The transaction with US-based Viatris required regulatory approvals from the Reserve Bank of India, Competition Commission of India and the US Federal Trade Commission, among others.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/EC2ubGw
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business
https://ift.tt/6oPi7Eq
No comments:
Post a Comment